Company / Free Cash Flow
CASTLE BIOSCIENCES INC Free Cash Flow History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$28.3M
FY2025
5-year range
-$47.3M / $36.5M
FY2021-FY2025
Trend
-22.5%
vs FY2024
Sector context
#104 of 150
Health Care
What the data says
At $28M, CASTLE BIOSCIENCES INC's free cash flow ranks #104 of 150 in the Health Care sector. Free Cash Flow has fluctuated over the past 8 years, ranging from -$47M in FY2022 to $37M in FY2024.
Based on SEC 10-K filings.
$28M in FY2025 with a 5-year CAGR of +40.8%.
Improved from -$19M to $28M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +40.8%
- 10-Year CAGR
- -
Sector benchmark
#104 of 150 in Health CareTop 69% of 150This company $28.3M Sector average $782.1M
▼
-96.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +40.8%, indicating consistent growth.
- In FY2025, free cash flow decreased 22.5% year-over-year.
- Ranks #104 out of 150 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $28.3M | -22.5% |
| FY2024 | $36.5M | +289.8% |
| FY2023 | -$19.2M | +59.3% |
| FY2022 | -$47.3M | -110.5% |
| FY2021 | -$22.5M | -539.3% |
| FY2020 | $5.1M | -15.9% |
| FY2019 | $6.1M | +148.3% |
| FY2018 | -$12.6M | - |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026